NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ophthalytics Inc

Ophthalytics Inc

Private
Marietta, GeorgiaHealthcare & Life Scienceshttps://360intelligentdiagnostics.com/

Last Round

Accelerator

Oct 24, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ophthalytics Inc is a healthcare technology company that provides an AI-based diagnostic platform for the early detection and diagnosis of ophthalmic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

diabetic retinopathy screeningAI medical diagnosismedical imaging AIophthalmology AIretinal image analysispoint-of-care diagnosticscomputer visionSaaS platformhealth equity technologypay-per-exam modelusage-based billingcamera-agnosticHIPAA compliantclinical trial supportFDA clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ophthalytics Inc Comparables

Compare Ophthalytics Inc with similar companies based on industry and business-model similarity.

Ophthalytics Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Ophthalytics Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 24, 2024
AcceleratorJul 15, 2024
AcceleratorJul 12, 2023

Key People

Founding team and executive leadership

Awais Bajwa

Founder & CEO

Founding Team

Ophthalytics Inc Investors

Notable investors and investment history

Ophthalytics Inc investors
InvestorRounds
Creative Destruction LabAccelerator
MATTERAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Grew 30% QoQ, from 10 to 13 employees.

  • Feb 25, 2026

    Grew 50% QoQ from 8 to 12 employees.

Ophthalytics Inc Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ophthalytics Inc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ophthalytics Inc's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarietta, Georgia
Employee Range14
Year Founded2020
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.